Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic Effects of Rifampicin on Famitinib in Healthy Males
NCT04494659Phase 1Completed
- Sponsor
- Hengrui
- Start
- Jul 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of famitinib in solid tumor, sponsored by Hengrui. Primary endpoints: Peak Plasma Concentration, Area Under the Curve to Last Timepoint and 1 more. Started Jul 2020; status: completed.
02
Drugs
famitinib
03
Conditions
solid tumor
Beyond the preview
Go deeper on NCT04494659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04494659.